Decoding Risks and Rewards in Ischemic Stroke Surgery - Trial NCT06098066
Access comprehensive clinical trial information for NCT06098066 through Pure Global AI's free database. This phase not specified trial is sponsored by China Medical University Hospital and is currently Completed. The study focuses on Ischemic Stroke. Target enrollment is 204411 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
China Medical University Hospital
Timeline & Enrollment
N/A
May 01, 2020
Jan 31, 2023
Primary Outcome
rehospitalization
Summary
In the high-stakes battle against ischemic cerebrovascular disease, where every second counts
 and the margin for error is slim, how do the investigators tip the scales in favor of patient
 survival and improved outcomes? This groundbreaking study, the first nationwide,
 population-based analysis with long-term follow-up in an Asian context, dives deep into this
 critical question. Leveraging an expansive dataset from Taiwan's National Health Insurance
 Research Database, the investigators scrutinize the efficacy and risks of aggressive surgical
 interventions-specifically, EC-IC bypass, CEA, and CAS-in a cohort of over 84,000 patients.
 
 This paper serves as a milestone, bridging the gap between medical idealism and clinical
 reality. It calls for a surgical renaissance, emphasizing the need for refining techniques
 and enhancing patient selection protocols. If participants're looking for a comprehensive,
 nuanced, and, above all, actionable insight into the surgical treatment of ischemic
 cerebrovascular disease, this is the study that could redefine the paradigm.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06098066
Non-Device Trial